» Articles » PMID: 35130043

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)

Abstract

Purpose: GOG-259 was a 3-arm randomized controlled trial of two web-based symptom management interventions for patients with recurrent ovarian cancer. Primary aims were to compare the efficacy of the nurse-guided (Nurse-WRITE) and self-directed (SD-WRITE) interventions to Enhanced Usual Care (EUC) in improving symptoms (burden and controllability) and quality of life (QOL).

Methods: Patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer with 3+ symptoms were eligible for the study. Participants completed baseline (BL) surveys (symptom burden and controllability and QOL) before random assignment. WRITE interventions lasted 8 weeks to develop symptom management plans for three target symptoms. All women received EUC: monthly online symptom assessment with provider reports; online resources; and every 2-week e-mails. Outcomes were evaluated at 8 and 12 weeks after BL. Repeated-measures modeling with linear contrasts evaluated group by time effects on symptom burden, controllability, and QOL, controlling for key covariates.

Results: Participants (N = 497) reported mean age of 59.3 ± 9.2 years. At BL, 84% were receiving chemotherapy and reported a mean of 14.2 ± 4.9 concurrent symptoms, most commonly fatigue, constipation, and peripheral neuropathy. Symptom burden and QOL improved significantly over time ( < .001) for all three groups. A group by time interaction ( < .001) for symptom controllability was noted whereby both WRITE intervention groups had similar improvements from BL to 8 and 12 weeks, whereas EUC did not improve over time.

Conclusion: Both WRITE Intervention groups showed significantly greater improvements in symptom controllability from BL to 8 and BL to 12 weeks compared with EUC. There were no significant differences between Nurse-WRITE and SD-WRITE. SD-WRITE has potential as a scalable intervention for a future implementation study.

Citing Articles

Design and Use of Patient-Facing Electronic Patient-Reported Outcomes and Sensor Data Visualizations During Outpatient Chemotherapy.

Bartel C, Chen L, Huang W, Li Q, Li Q, Fedor J JMIR Cancer. 2025; 11():e62711.

PMID: 39801398 PMC: 11741193. DOI: 10.2196/62711.


Needs of Patients With Gynecologic Cancer and Their Caregivers for Obtaining mHealth-Supported Self-Management: Focus Group Study.

Campbell G, Kim H, Klinedinst T, Klinger J, Lee Y, Donovan H JMIR Cancer. 2024; 10:e48465.

PMID: 39361371 PMC: 11487211. DOI: 10.2196/48465.


Integrating Family Caregivers Into Cancer Care: Implementation of Evidence-Based Caregiver Protocols Into Gynecologic Oncology Practice.

Thomas T, Campbell G, Tan K, Murray P, Loughlin K, Roberge M JCO Oncol Pract. 2024; :OP2400383.

PMID: 39167743 PMC: 11842612. DOI: 10.1200/OP.24.00383.


Measuring Engagement in Provider-Guided Digital Health Interventions With a Conceptual and Analytical Framework Using Nurse WRITE as an Exemplar: Exploratory Study With an Iterative Approach.

Wang Y, DeVito Dabbs A, Thomas T, Campbell G, Donovan H JMIR Form Res. 2024; 8:e57529.

PMID: 39037757 PMC: 11301115. DOI: 10.2196/57529.


Women with ovarian cancer's information seeking and avoidance behaviors: an interview study.

Chi Y, Hui V, Kunsak H, Brusilovsky P, Donovan H, He D JAMIA Open. 2024; 7(1):ooae011.

PMID: 38384330 PMC: 10881099. DOI: 10.1093/jamiaopen/ooae011.


References
1.
Scheier M, Carver C, Bridges M . Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994; 67(6):1063-78. DOI: 10.1037//0022-3514.67.6.1063. View

2.
Ward S, Wang K, Serlin R, Peterson S, Murray M . A randomized trial of a tailored barriers intervention for Cancer Information Service (CIS) callers in pain. Pain. 2009; 144(1-2):49-56. PMC: 2875780. DOI: 10.1016/j.pain.2009.02.021. View

3.
Hann D, Winter K, Jacobsen P . Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999; 46(5):437-43. DOI: 10.1016/s0022-3999(99)00004-5. View

4.
Schou-Bredal I, Heir T, Skogstad L, Bonsaksen T, Lerdal A, Grimholt T . Population-based norms of the Life Orientation Test-Revised (LOT-R). Int J Clin Health Psychol. 2018; 17(3):216-224. PMC: 6220921. DOI: 10.1016/j.ijchp.2017.07.005. View

5.
Donovan H, Ward S, Song M, Heidrich S, Gunnarsdottir S, Phillips C . An update on the representational approach to patient education. J Nurs Scholarsh. 2007; 39(3):259-65. PMC: 2526460. DOI: 10.1111/j.1547-5069.2007.00178.x. View